ARP (USA) Pty Ltd has been granted the rights to commercialize 4JOINTZ® in the USA by Arthritis Relief Plus Ltd, an Australian Biotechnology company, which has developed, patented and successfully completed clinical studies of its unique botanical topical (4JOINTZ®) i.e., pain relief cream & gel for effective treatment of hip pain, arthritis, stiffness and swelling associated with osteoarthritis and other joint conditions.
It is anticipated that the 4JOINTZ® technology could potentially provide significant cost savings for the community by delaying the need for surgery and reducing medical intervention associated with the side effects of commonly used Non-Steroidal Anti Inflammatory Drugs (NSAIDS). 4JOINTZ® improves the quality of life for osteoarthritis sufferers providing relief for painful, stiff and swollen joints.